About this document
Synergistic MERS-CoV Treatment Strategy by hangchenhu4991 is a document available to read on EtoBox.
This study investigates the synergistic effects of a fusion inhibitory peptide (HR2P-M2) and a neutralizing antibody (m336) against MERS-CoV, which poses a significant public health threat due to the lack of effective treatments. The combination of these two agents showed enhanced antiviral activity against both wild-type and mutant strains of MERS-CoV, suggesting a promising therapeutic strategy for infected patients. The findings indicate that this combinatorial approach could be developed for clinical us
- Author
- hangchenhu4991
- Language
- EN